Author:
Haferlach Torsten,Schnittger Susanne,Schoch Claudia
Publisher
Springer Berlin Heidelberg
Reference69 articles.
1. Barosi G (1999) Myelofibrosis with myeloid metaplasia: diagnostic definition and prognostic classification for clinical studies and treatment guidelines. J Clin Oncol 17:2954–2970
2. Bench AJ, Nacheva EP, Champion KM, Green AR (1998) Molecular genetics and cytogenetics of myeloprolifearative disorders. Baillieres Clin Haematol 11:819–848
3. Ben Neriah Y, Daley GQ, Mes Masson AM, Witte ON, Baltimore D (1986) The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene. Science 233:212–214
4. Bennett JM, Catovsky D, Daniel MT et al. (1994) The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposal by the French-American-British Cooperative Leukaemia Group. Br J Haematol 87:746–754
5. Berk D, Goldberg JD, Donovan PB, Fruchtman SM, Berlin MI, Wasserman LR (1986) Therapeutic recommendations in polycythemia vera based on polycythemia study group protocols. Semin Hematol 23:132–143